Personal information

No personal information available

Activities

Collapse all

Employment (3)

A*STAR Graduate Academy: Singapore, SG

2024-01 to present | PhD Student (Infectious Diseases Lab)
Employment
Source: Self-asserted source
Thomas VALLET

CIRI: Lyon, FR

2022-09 to 2023-12 | Engineer
Employment
Source: Self-asserted source
Thomas VALLET

Institut Pasteur: Paris, Île-de-France, FR

2016-02-21 to 2022-09 | Research assistant (Virology)
Employment
Source: Self-asserted source
Thomas VALLET

Works (7)

Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen

Nature Communications
2022-05-04 | Journal article
DOI: 10.1038/s41467-022-30134-9
Contributors: Alice Mac Kain; Ghizlane Maarifi; Sophie-Marie Aicher; Nathalie Arhel; Artem Baidaliuk; Sandie Munier; Flora Donati; Thomas Vallet; Quang Dinh Tran; Alexandra Hardy et al.
Source: check_circle
Crossref

A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection

EMBO reports
2022-02-03 | Journal article
DOI: 10.15252/embr.202154341
Contributors: Meetali Singh; Maxime Chazal; Piergiuseppe Quarato; Loan Bourdon; Christophe Malabat; Thomas Vallet; Marco Vignuzzi; Sylvie van der Werf; Sylvie Behillil; Flora Donati et al.
Source: check_circle
Crossref

Induced intra- and intermolecular template switching as a therapeutic mechanism against RNA viruses

Molecular Cell
2021-11 | Journal article
DOI: 10.1016/j.molcel.2021.10.003
Contributors: Richard Janissen; Andrew Woodman; Djoshkun Shengjuler; Thomas Vallet; Kuo-Ming Lee; Louis Kuijpers; Ibrahim M. Moustafa; Fiona Fitzgerald; Peng-Nien Huang; Angela L. Perkins et al.
Source: check_circle
Crossref

A virus-encoded microRNA contributes to evade innate immune response during SARS-CoV-2 infection

2021-09-09 | Other
DOI: 10.1101/2021.09.09.459577
Contributors: Meetali Singh; Maxime Chazal; Piergiuseppe Quarato; Loan Bourdon; Christophe Malabat; Thomas Vallet; Marco Vignuzzi; Sylvie van der Werf; Sylvie Behillil; Flora Donati et al.
Source: check_circle
Crossref

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Science
2021-07-30 | Journal article
DOI: 10.1126/science.abi4708
Contributors: Tia A. Tummino; Veronica V. Rezelj; Benoit Fischer; Audrey Fischer; Matthew J. O’Meara; Blandine Monel; Thomas Vallet; Kris M. White; Ziyang Zhang; Assaf Alon et al.
Source: check_circle
Crossref

Phospholipidosis is a shared mechanism underlying thein vitroantiviral activity of many repurposed drugs against SARS-CoV-2

2021-03-24 | Preprint
DOI: 10.1101/2021.03.23.436648
Contributors: Tia A. Tummino; Veronica V. Rezelj; Benoit Fischer; Audrey Fischer; Matthew J. O’Meara; Blandine Monel; Thomas Vallet; Ziyang Zhang; Assaf Alon; Henry R. O’Donnell et al.
Source: check_circle
Crossref

Defective viral genomes from chikungunya virus are broad-spectrum antivirals and prevent virus dissemination in mosquitoes

PLOS Pathogens
2021-02-08 | Journal article
DOI: 10.1371/journal.ppat.1009110
Contributors: Laura I. Levi; Adam S. Lauring; Veronica V. Rezelj; Annabelle Henrion-Lacritick; Diana Erazo; J Boussier; Thomas Vallet; Veronika Bernhauerová; Yasutsugu Suzuki; Lucia Carrau et al.
Source: check_circle
Crossref
How many people are using ORCID?